Stock Analiz

Prelude Therapeutics Inc (PRLD) stock forecast and price target

Price $3.45 · data as of November 13, 2026

12-month price target

Average target$9.20
Upside / downside+166.7%
Analysts5
ConsensusNone
Low $6.00Average $9.20High $12.00

Gold marker: average target · white marker: today’s price ($3.45)

Analyst ratings

Strong buy 2Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.57+56.1%$39M
Next fiscal year
ends December 31, 2027
$-0.58−2.4%$36M
Quarter after
ends December 31, 2026
$-0.15+24.1%$4M

Consensus of the analysts covering Prelude Therapeutics, updated daily.

Frequently asked questions

What is the Prelude Therapeutics stock price target?

The average 12-month target from 5 analysts is $9.20, 166.7% above the current price of $3.45 Targets range from $6.00 to $12.00.

Is Prelude Therapeutics a buy according to analysts?

The consensus rating is “None” (2 strong buy, 3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Prelude Therapeutics expected to earn?

Analysts expect EPS of $-0.57 for the fiscal year ending December 31, 2026 and $-0.58 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.